Home › Agent Hub › Agent Tools › Part D coverage by drug › Rabeprazole
Agent Tools
Rabeprazole is a generic drug. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 4,341 of 5,492 Medicare Part D and Medicare Advantage drug plans (79%) list Rabeprazole on their formulary, across 215 of 286 formularies. The most common placement is tier 3 (2,701 plans, 62.2% of those covering it). 0 of the covering plans require prior authorization (0%), 14 step therapy and 3,086 a quantity limit.
910 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $0, 542 of them $0; 3,431 charge coinsurance instead — median 24% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 4,012 of 5,496 plans covered it (73%); 2027: 4,341 of 5,492 (79%).
Of 4,367 plans offered in both years, 390 added it to the formulary and 26 dropped it.
Among plans covering it both years, 56 moved it to a higher tier and 216 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 408 |
| Tier 2 | 478 |
| Tier 3 | 2,701 |
| Tier 4 | 754 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 103 of 323 | 31.9% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,539 of 3,200 | 79.3% | 0% |
| Special needs plans (SNP) | 1,699 of 1,969 | 86.3% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 744 of 846 | Tier 3 | 0 |
| UnitedHealthcare | 796 of 830 | Tier 3 | 0 |
| Devoted Health | 446 of 728 | Tier 3 | 0 |
| Aetna Medicare | 631 of 631 | Tier 4 | 0 |
| Wellcare | 234 of 268 | Tier 1 | 0 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 2 | 0 |
| Alignment Health Plan | 77 of 77 | Tier 2 | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 0 |
| Wellpoint | 63 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 40 of 40 | Tier 4 | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 3 | 0 |
| Zing Health | 6 of 36 | Tier 3 | 0 |
| Capital Blue Cross | 35 of 35 | Tier 2 | 0 |
| Prominence Health Plan | 29 of 29 | Tier 2 | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 0 of 26 | No tier listed | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 84 of 114 | 73.7% |
| Alaska | 3 of 9 | 33.3% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 124 of 147 | 84.4% |
| Arkansas | 60 of 85 | 70.6% |
| California | 336 of 397 | 84.6% |
| Colorado | 74 of 106 | 69.8% |
| Connecticut | 40 of 54 | 74.1% |
| Delaware | 29 of 43 | 67.4% |
| District of Columbia | 8 of 12 | 66.7% |
| Florida | 462 of 545 | 84.8% |
| Georgia | 109 of 149 | 73.2% |
| Guam | 1 of 1 | 100% |
| Hawaii | 26 of 50 | 52% |
| Idaho | 30 of 45 | 66.7% |
| Illinois | 91 of 132 | 68.9% |
| Indiana | 110 of 138 | 79.7% |
| Iowa | 55 of 64 | 85.9% |
| Kansas | 71 of 84 | 84.5% |
| Kentucky | 104 of 121 | 86% |
| Louisiana | 98 of 125 | 78.4% |
| Maine | 44 of 52 | 84.6% |
| Maryland | 22 of 49 | 44.9% |
| Massachusetts | 62 of 89 | 69.7% |
| Michigan | 120 of 182 | 65.9% |
| Minnesota | 43 of 63 | 68.3% |
| Mississippi | 77 of 104 | 74% |
| Missouri | 137 of 170 | 80.6% |
| Montana | 19 of 27 | 70.4% |
| Nebraska | 37 of 51 | 72.5% |
| Nevada | 89 of 100 | 89% |
| New Hampshire | 16 of 25 | 64% |
| New Jersey | 60 of 73 | 82.2% |
| New Mexico | 54 of 68 | 79.4% |
| New York | 187 of 215 | 87% |
| North Carolina | 138 of 176 | 78.4% |
| North Dakota | 14 of 26 | 53.8% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 123 of 171 | 71.9% |
| Oklahoma | 65 of 81 | 80.2% |
| Oregon | 66 of 92 | 71.7% |
| Pennsylvania | 287 of 323 | 88.9% |
| Puerto Rico | 1 of 64 | 1.6% |
| Rhode Island | 21 of 29 | 72.4% |
| South Carolina | 70 of 89 | 78.7% |
| South Dakota | 16 of 30 | 53.3% |
| Tennessee | 119 of 156 | 76.3% |
| Texas | 352 of 407 | 86.5% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 44 of 53 | 83% |
| Vermont | 6 of 14 | 42.9% |
| Virginia | 119 of 144 | 82.6% |
| Washington | 80 of 114 | 70.2% |
| West Virginia | 58 of 69 | 84.1% |
| Wisconsin | 81 of 96 | 84.4% |
| Wyoming | 5 of 13 | 38.5% |
Medicare Part D paid for 636,780 30-day fills of Rabeprazole in 2024 for about 79,278 enrollees, at an average total cost of $20.06 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Rabeprazole and the rest of a client's list on every plan in their county.
Estimate Rabeprazole costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.